Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue 9, Pages 2354-2360
Publisher
Oxford University Press (OUP)
Online
2013-05-24
DOI
10.1093/annonc/mdt197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands
- (2013) Linda Mol et al. ACTA ONCOLOGICA
- Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada
- (2012) Lindsay Hedden et al. EUROPEAN JOURNAL OF CANCER
- Treatment strategies for patients with stage IV rectal cancer: A report from the Swedish Rectal Cancer Registry
- (2012) M. Hosseinali Khani et al. EUROPEAN JOURNAL OF CANCER
- Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
- (2012) Kjell Magne Tveit et al. JOURNAL OF CLINICAL ONCOLOGY
- Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992–2008
- (2011) V. E. P. P. Lemmens et al. CLINICAL & EXPERIMENTAL METASTASIS
- Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer
- (2011) Muhammad A. Khattak et al. EUROPEAN JOURNAL OF CANCER
- Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
- (2011) Matthew T Seymour et al. LANCET
- Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009
- (2010) R. Adam et al. ANNALS OF ONCOLOGY
- Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006
- (2010) L. N. van Steenbergen et al. ANNALS OF ONCOLOGY
- Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
- (2010) L J M Mekenkamp et al. BRITISH JOURNAL OF CANCER
- Surgical management and outcomes of colorectal cancer liver metastases
- (2010) E. J. A. Morris et al. BRITISH JOURNAL OF SURGERY
- Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer
- (2010) Hendrik-Tobias Arkenau et al. CANCER
- Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006
- (2010) M.A.G. Elferink et al. EUROPEAN JOURNAL OF CANCER
- Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients
- (2009) Halfdan Sorbye et al. CANCER
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Ageing populations: the challenges ahead
- (2009) Kaare Christensen et al. LANCET
- Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004
- (2008) H. J. Meulenbeld et al. ANNALS OF ONCOLOGY
- Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness
- (2008) Inger Kristin Larsen et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started